Target Group, Inc. (Canada) (CBDY)
0.0012
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Target Group Cash from Operations (Quarterly) : -0.2229M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2229M |
| March 31, 2026 | -0.0937M |
| December 31, 2025 | -0.2508M |
| September 30, 2025 | -0.5061M |
| June 30, 2025 | 0.4844M |
| March 31, 2025 | -0.57M |
| December 31, 2024 | 0.7364M |
| September 30, 2024 | -0.3293M |
| June 30, 2024 | 0.9811M |
| March 31, 2024 | 0.7744M |
| December 31, 2023 | 0.2897M |
| September 30, 2023 | -0.5705M |
| June 30, 2023 | -0.1221M |
| March 31, 2023 | -0.1868M |
| December 31, 2022 | 0.0554M |
| September 30, 2022 | 0.129M |
| June 30, 2022 | -1.347M |
| March 31, 2022 | 0.148M |
| December 31, 2021 | 0.608M |
| September 30, 2021 | -0.2362M |
| June 30, 2021 | -0.3663M |
| March 31, 2021 | 0.0947M |
| December 31, 2020 | -0.2134M |
| September 30, 2020 | -0.285M |
| June 30, 2020 | -0.0648M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.87M |
| December 31, 2019 | -0.0842M |
| September 30, 2019 | -2.509M |
| June 30, 2019 | -1.804M |
| March 31, 2019 | -1.118M |
| December 31, 2018 | 0.1892M |
| September 30, 2018 | -0.7783M |
| June 30, 2018 | -0.0554M |
| March 31, 2018 | -0.055M |
| December 31, 2017 | -0.0567M |
| September 30, 2017 | -0.0617M |
| June 30, 2017 | -0.0729M |
| March 31, 2017 | -0.0709M |
| December 31, 2016 | -0.008M |
| September 30, 2016 | -0.1589M |
| June 30, 2016 | -0.1437M |
| March 31, 2016 | -0.1104M |
| December 31, 2015 | -0.0519M |
| September 30, 2015 | -0.0294M |
| June 30, 2015 | -0.0436M |
| March 31, 2015 | -0.0551M |
| December 31, 2014 | -0.0067M |
| September 30, 2014 | -0.0024M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.635M |
| InMed Pharmaceuticals, Inc. | -1.759M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.53M |
| Clearmind Medicine, Inc. | -1.792M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0065M |
| Cash from Financing (Quarterly) | 0.0309M |
| Free Cash Flow | -1.168M |
| Free Cash Flow Per Share (Quarterly) | -0.0004 |
| Free Cash Flow to Equity (Quarterly) | -0.0065M |
| Free Cash Flow to Firm (Quarterly) | 0.0598M |
| Free Cash Flow Yield | -157.7% |